ERSP tells Brazilian Basics to forget Alzheimer's claim
This article was originally published in The Tan Sheet
Executive SummaryThe claim that the AO3 Boomer Berry dietary supplement "Lowers the risk of developing Alzheimer's" is an unsupported disease claim and should be discontinued, the Electronic Retailing Self-Regulation Program says. However, other cognitive health claims Brazilian Basics makes for the acai berry and omega-3 fish oil product -- "Sharpen your concentration" and "Improve your mental clarity" -- are adequately substantiated, the unit of the Council of Better Business Bureaus said July 24. ERSP also advised the firm on AO3 Boomer Berry's claims related to joint support, heart health and increased energy. Tampa, Fla.-based Brazilian Basics said it "will use ERSP's views and recommendations to make revisions in its future advertising" of the product
You may also be interested in...
Eighteen years of free trade threatens to crash, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.